youtube_live
Penghasilan pada Q3 2026 • dirilis • EPS melampaui perkiraan +8,62% • Pendapatan melampaui perkiraan +2,31%
Lihat hasilchevron_right
EW:NYSE
Edwards Lifesciences Corp
US$99,37
arrow_upward
+4,38%(+4,17) 1 HR
US$103,00
arrow_upward
+3,65% (+3,63)bedtimeSetelah jam perdagangan normal
Tutup: 4 Nov, 16.00.04 GMT-5 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk EW...
Pembukaan
US$98,58
Tinggi
US$100,25
Rendah
US$96,72
Kapitalisasi pasar
57,28 M
Volume rata-rata
4,00 jt
Volume
7,90 jt
Rasio P/E
57,49
Harga tinggi dalam 52 minggu terakhir
US$100,25
Harga rendah dalam 52 minggu terakhir
US$74,66
EPS
US$1,73
Beta
0,85
Saham beredar
576,40 jt
Jumlah karyawan
16 rb
Pembukaan
US$98,58
Tinggi
US$100,25
Rendah
US$96,72
Kapitalisasi pasar
57,28 M
Volume rata-rata
4,00 jt
Volume
7,90 jt
Rasio P/E
57,49
Harga tinggi dalam 52 minggu terakhir
US$100,25
Harga rendah dalam 52 minggu terakhir
US$74,66
EPS
US$1,73
Beta
0,85
Saham beredar
576,40 jt
Jumlah karyawan
16 rb
Artikel berita
Dari sumber web dan partner berita
BigGo Finance
·
7 jam yang lalu
[Edwards Lifesciences Q3 2026 Earnings Call] Edwards Raises Full-Year Guidance to 11.5% Sales Growth and $3.01 EPS Midpoint After Q3 Beat; TAVR Growth to Rely on Market Expansion, Not Share Gains
GuruFocus
·
8 jam yang lalu
Edwards Lifesciences (EW) Q3 Earnings Beat Expectations, Raises Guidance
Benzinga
·
9 jam yang lalu
Edwards Lifesciences Q3 2026 Earnings Call Transcript
Investing.com
·
10 jam yang lalu
Edwards Lifesciences earnings beat by $0.06, revenue topped estimates
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Tentang Edwards Lifesciences Corp
CEO-
Karyawan16 rb
Didirikan1958
Kantor PusatIrvine, California, Amerika Serikat
Sektor-
Industry-
Situsedwards.com